"10.1371_journal.pone.0077828","plos one","2013-10-30T00:00:00Z","Jérémy Ferrier; Mathilde Bayet-Robert; Bruno Pereira; Laurence Daulhac; Alain Eschalier; Denis Pezet; Jacques-Philippe Moulinoux; David Balayssac","Clermont Université, Université dAuvergne, Pharmacologie Fondamentale et Clinique de la Douleur, Clermont-Ferrand, France; INSERM, U1107 NEURO-DOL, Clermont-Ferrand, France; CHU Clermont-Ferrand, Clermont-Ferrand, France; Groupe de Recherche en Thérapeutique Anticancéreuse, EA 3891, Université de Rennes 1, Rennes, France","Conceived and designed the experiments: JF MBR LD JPM DP DB. Performed the experiments: JF MBR DB. Analyzed the data: JF MBR BP. Contributed reagents/materials/analysis tools: JF MBR JPM DP LD. Wrote the paper: JF MBR JPM BP AE DB.","JPM is a co-founder of Nutrialys, a R&D company commercializing low polyamine content nutritional supplements. The authors declare a patent on the concept on polyamine deficient diet to prevent oxaliplatin-induced neuropathy (FR 2967868 (A1) - Utilisation dune composition alimentaire dans le traitement et/ou la prévention des douleurs neuropathiques induites par un agent anticancereux). There are no products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.",NA,NA,NA,"2013","10","Jérémy Ferrier","JF",8,TRUE,6,3,3,6,TRUE,TRUE,FALSE,0,NA,FALSE
